A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS).

Akihiko Miyanaga,Hajime Asahina,Satoshi Watanabe,Takehito Shukuya,Yukari Tsubata,Yukio Hosomi,Shunichi Sugawara,Makoto Maemondo,Tetsuya Okano,Satoshi Morita,Kotone Matsuyama,Kunihiko Kobayashi,Masahiro Seike

Clinical lung cancer（2023）

引用 0|浏览11

暂无评分

摘要

This is the first study to investigate the efficacy and safety of necitumumab plus pembrolizumab combined with platinum-based chemotherapy in patients with previously untreated SqCLC.

查看译文

关键词

Chemotherapy,Clinical trial,Phase I/II,necitumumab,squamous NSCLC

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要